Drug Trial Radar · NCT05629962
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Last checked: Nov 20, 2026Latest source record: Jun 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,285
Actual
Start
Nov 25, 2022
Primary completion
Apr 25, 2024
Study completion May 30, 2024
Sponsor
- Lead sponsor
- Atea Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 29, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible subjects will be randomly assigned (by chance) to receive BEM or matching placebo orally for 5 days. Co-administration of locally available standard of care (SOC) is allowed. The total duration of the study is 60 days.
Conditions
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
- COVID-19
Interventions
Bemnifosbuvir (BEM)Drug
BEM tablets administered orally every 12 hours (twice a day) for a total of 5 days
PlaceboDrug
Placebo tablets administered orally every 12 hours (twice a day) for a total of 5 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Hospitalized for Any Cause or Died Due to Any CauseTime frame: Day 1 through Day 29
Locations
263 sites in 19 countries. Site status is shown where the registry gives one.
Atea Study Site
Kingman, Arizona
Atea Study Site
Prescott, Arizona
Atea Study Site
Surprise, Arizona
Atea Study Site
Tucson, Arizona
Atea Study Site
Canoga Park, California
Atea Study Site
Fullerton, California
Atea Study Site
Inglewood, California
Atea Study Site
La Palma, California
Atea Study Site
Long Beach, California
Atea Study Site
Long Beach, California
Atea Study Site
Los Angeles, California
Atea Study Site
Sacramento, California
Atea Study Site
San Diego, California
Atea Study Site
Coral Gables, Florida
Atea Study Site
Cutler Bay, Florida
Atea Study Site
Doral, Florida
Atea Study Site
Hialeah, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami, Florida
Atea Study Site
Miami Gardens, Florida
Atea Study Site
North Miami Beach, Florida
Atea Study Site
North Miami Beach, Florida
Atea Study Site
Pembroke Pines, Florida
Atea Study Site
Pompano Beach, Florida
Atea Study Site
Tampa, Florida
Atea Study Site
Tampa, Florida
Atea Study Site
Tampa, Florida
Atea Study Site
Tampa, Florida
Atea Study Site
The Villages, Florida
Atea Study Site
West Miami, Florida
Atea Study Site
West Palm Beach, Florida
Atea Study Site
Eatonton, Georgia
Atea Study Site
Orland Park, Illinois
Atea Study Site
La Vista, Nebraska
Atea Study Site
The Bronx, New York
Showing 40 of 263 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.